Yes, doctors can prescribe BPC-157 only where local law allows access to an unapproved or compounded drug , but BPC-157 has no FDA-approved prescription product for any medical condition
In simple terms, a substance generally must meet one of these requirements: It has an official USP or National Formulary monograph It is already part of an FDA-approved drug product It appears on the FDAs official 503A Bulks List The important point is this: BPC-157, TB-500, and injectable GHK-Cu are not FDA-approved drugs, and they are not currently on the formal 503A Bulks List
Its clinical use is investigational: no human clinical trials have been completed to regulatory approval standards for any BPC-157 formulation
Available Sizes: 8oz or 16oz
Receiving shipments promptly and transferring to refrigeration quickly preserves potency.
Sublingual preparations are available, though evidence for their superiority over standard oral tablets is limited, and they are not routinely recommended in UK clinical practice